Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

Clinicaltrials.gov ID: NCT06039085
db-list-check Status RECRUITING
b-loader Phase
b-people Age ≥ 18 Years
b-bullseye-arrow Enrollments 200

Conditions

Prostate Cancer

Summary

This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.

Detailed Description

Two hundred men will be recruited to participate in this trial. Consent will be obtained from all participating men prior to surgery.

The trial will consist of recording EII data from:

1. In vivo pelvic floor and peri-prostatic tissues remaining after the prostate has been resected
2. Resected ex vivo prostate following extraction from the abdomen (in the OR)
3. Resected ex vivo prostate when transferred to Pathology, post-RARP

The study team will also track post-surgical complications due to the study’s technology (e.g., infection) and additional time required to deploy the study technology used to assess feasibility of clinical integration of the EII device. Post-RARP pathological assessment of margin tissues will be used to train and evaluate the study’s classification schemes for identifying Positive Surgical Margin (PSMs).

Locations

1 location Found with status Recruiting

Status

  • RECRUITING

Contact Person

Principal Investigator

  • Ryan J Halter, PhD

Eligibility Criteria

Inclusion Criteria:

1. Clinical diagnosis of prostate cancer requiring RARP.
2. Ability to understand and the willingness to sign a written informed consent document.
3. Age ≥ 18 years old

Exclusion Criteria:

1. Adults with implanted electrical devices such as pacemakers
2. Prisoners
3. Adults with impaired decision-making capacity
4. Any condition for which, in the opinion of the investigator, contraindicates study participation.

Outcome Measures

Primary Outcome Measures

Electrical impedance difference between positive and negative surgical margins

Time Frame: 2023-2025

Secondary Outcome Measures

Safety of EI sensing in vivo electrical sensing

Time Frame: 2023-2025

Efficacy of EI sensing in vivo electrical sensing

Time Frame: 2023-2025

Timeline

  • Last Updated
    January 24, 2024
  • Start Date
    September 15, 2023
  • Today
    February 5, 2025
  • Completion Date ( Estimated )
    December 31, 2026

Similar Trials

light-list-check RECRUITING light-blue-people 21 - 64 Years
light-list-check RECRUITING light-blue-people ≥ 18 Years
light-list-check RECRUITING light-blue-people ≥ 65 Years